Protalix BioTherapeutics
PLX
#8876
Rank
ยฃ0.16 B
Marketcap
ยฃ2.10
Share price
0.00%
Change (1 day)
14.54%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): ยฃ0.23

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.23. In 2025 the company made an earnings per share (EPS) of -ยฃ0.06057 a decrease over its 2024 EPS that were of ยฃ0.03028.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.23-485.89%
2025-ยฃ0.06057-300%
2024ยฃ0.03028-66.67%
2023ยฃ0.09085-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.47181.82%
2020-ยฃ0.17-82.11%
2019-ยฃ0.93-31.67%
2018-ยฃ1.36-72.31%
2017-ยฃ4.92124.14%
2016-ยฃ2.20-147.54%
2015ยฃ4.62-290.62%
2014-ยฃ2.426.67%
2013-ยฃ2.27130.77%
2012-ยฃ0.98-69.77%
2011-ยฃ3.2619.44%
2010-ยฃ2.73-12.2%
2009-ยฃ3.1036.67%
2008-ยฃ2.27-37.5%
2007-ยฃ3.6350%
2006-ยฃ2.423.23%
2005-ยฃ2.35138.46%
2004-ยฃ0.98-74%
2003-ยฃ3.79-0%
2002-ยฃ3.79-50%
2001-ยฃ7.57233.33%
2000-ยฃ2.27-84.21%
1999-ยฃ14.38-24%
1998-ยฃ18.93-600%
1997ยฃ3.79-16.67%
1996ยฃ4.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.58 145.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.34 2,174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08328-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.48 103.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel